Li Hongjing, Yang Qiaoling, Yin Xuedong, et al. Effects of Vancomycin on Kidney and Transporters in Mice with Different Administration Time[J]. 2022,28(3):1-5.
Li Hongjing, Yang Qiaoling, Yin Xuedong, et al. Effects of Vancomycin on Kidney and Transporters in Mice with Different Administration Time[J]. 2022,28(3):1-5. DOI: 10.13407/j.cnki.jpp.1672-108X.2022.03.001.
Objective: To probe into the correlation between nephrotoxicity of vancomycin (VCM) in mice and administration time and its mechanism of action. Methods: Twenty-five male C57BL/6 mice were randomly divided into the VCM (600 mg/kg
intraperitoneal injection
qd) 1 d group
VCM 3 d group
VCM 7 d group
VCM 10 d group and blank control group (normal saline)
with 5 mice in each group. The kidney weight of each group was weighed after the last administration of 24 h. The levels of creatinine and urea nitrogen in serum of mice were determined by the automatic biochemical analyzer. The morphological and structural changes of kidney tissues were observed by hematoxylin-eosin staining. The concentrations of VCM in serum and kidney of mice were determined by liquid chromatography-mass spectrometer (LC-MS). The mRNA expression of transporter-related genes in kidney was analyzed by real-time polymerase chain reaction (PCR). Results: Compared with the blank control group
VCM significantly increased the kidney weight
induced the kidney function damage and kidney pathological changes in a time dependent manner. After 3 d of VCM administration
there was slight accumulation in the kidney. After 7 d of VCM administration
VCM was highly accumulated in the kidney and serum. After intraperitoneal injection of VCM
the mRNA levels of organic cation transporter 2 (Oct2) and multidrug resistance associated protein 2 (Mrp2) in the early kidney were up-regulated
the mRNA levels of Oct1
Oct2
multidrug and toxin-excreting protein 1 (Mate1)
organic anion transporter 1 (Oat1)
Oat3 and Mrp2 in the middle and late kidney decreased significantly
while the mRNA levels of Mrp4 were not significantly changed. Conclusion: The mechanism of action of VCM may be related to the effects on kidney transporter expression as it starts to induce kidney damage 3 d after intraperitoneal administration